Kathryn E. Falberg's most recent trade in Arcus Biosciences Inc was a trade of 38,300 Stock Option (Rights to Buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 38,300 | 38,300 | - | - | Stock Option (Rights to Buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 13,300 | 68,600 (0%) | 0% | 0 | Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 4,901 | 101,901 (0%) | 0% | 0 | Class A Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 59.17 per share. | 27 May 2025 | 1,183 | 103,929 (0%) | 0% | 59.2 | 69,998 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 59.17 per share. | 27 May 2025 | 845 | 104,774 (0%) | 0% | 59.2 | 49,999 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 59.17 per share. | 27 May 2025 | 845 | 102,746 (0%) | 0% | 59.2 | 49,999 | Class A Common Stock |
| Nuvation Bio Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 292,983 | 292,983 | - | - | Stock Option (Right to Buy) | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 63.73 per share. | 15 Apr 2025 | 90 | 97,000 (0%) | 0% | 63.7 | 5,736 | Class A Common Stock |
| Nuvation Bio Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 200,801 | 200,801 | - | - | Stock Option (Right to Buy) | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 98.17 per share. | 13 Aug 2024 | 150,000 | 96,910 (0%) | 0% | 98.2 | 14,725,500 | Class A Common Stock |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 8,400 | 55,300 (0%) | 0% | 0 | Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 3,155 | 245,764 (0%) | 0% | 0 | Class A Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 87.16 per share. | 28 May 2024 | 573 | 246,910 (0%) | 0% | 87.2 | 49,943 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 87.16 per share. | 28 May 2024 | 573 | 246,337 (0%) | 0% | 87.2 | 49,943 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 103,030 | 0 | - | - | Employee Stock Option Exercise (Right to Buy) | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 103,030 | 103,030 | - | - | Class B Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | 08 Mar 2024 | 103,030 | 0 | - | - | Class B Common Stock | ||
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | 08 Mar 2024 | 103,030 | 345,639 (0%) | 0% | 1.8 | 185,763 | Class A Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 81.90 per share. | 08 Mar 2024 | 102,935 | 242,704 (0%) | 0% | 81.9 | 8,430,377 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 82.36 per share. | 08 Mar 2024 | 95 | 242,609 (0%) | 0% | 82.4 | 7,824 | Class A Common Stock |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Jun 2023 | 50,504 | 40,100 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 19,500 | 19,500 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 6,800 | 46,900 (0%) | 0% | 0 | Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 4,238 | 241,011 (0%) | 0% | 0 | Class A Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 62.52 per share. | 25 May 2023 | 799 | 241,810 (0%) | 0% | 62.5 | 49,953 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 62.52 per share. | 25 May 2023 | 799 | 242,609 (0%) | 0% | 62.5 | 49,953 | Class A Common Stock |
| Nuvation Bio Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 366,744 | 366,744 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc Ordinary | Kathryn E. Falberg | Director | Purchase of securities on an exchange or from another person at price $ 1.97 per share. | 30 Nov 2022 | 84,959 | 160,000 | - | 2.0 | 167,599 | Class A Common Stock |
| Nuvation Bio Inc Ordinary | Kathryn E. Falberg | Director | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 30 Nov 2022 | 75,041 | 75,041 | - | 1.9 | 139,088 | Class A Common Stock |
| Nuvation Bio Inc Ordinary | Kathryn E. Falberg | Director | Purchase of securities on an exchange or from another person at price $ 1.98 per share. | 30 Nov 2022 | 47,000 | 207,000 | - | 2.0 | 93,187 | Class A Common Stock |
| Nuvation Bio Inc Ordinary | Kathryn E. Falberg | Director | Purchase of securities on an exchange or from another person at price $ 1.95 per share. | 30 Nov 2022 | 43,000 | 250,000 | - | 2.0 | 83,962 | Class A Common Stock |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 16,800 | 16,800 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 4,100 | 90,604 (0%) | 0% | 0 | Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 4,178 | 235,588 (0%) | 0% | 0 | Class A Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 59.83 per share. | 26 May 2022 | 835 | 236,423 (0%) | 0% | 59.8 | 49,958 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 59.83 per share. | 26 May 2022 | 267 | 236,690 (0%) | 0% | 59.8 | 15,975 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 59.83 per share. | 26 May 2022 | 83 | 236,773 (0%) | 0% | 59.8 | 4,966 | Class A Common Stock |
| Nuvation Bio Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 140,713 | 140,713 | - | - | Stock Option (Right to Buy) | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 108.03 per share. | 19 Nov 2021 | 80,563 | 119,437 (0%) | 0% | 108.0 | 8,703,221 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 108.90 per share. | 19 Nov 2021 | 47,719 | 71,718 (0%) | 0% | 108.9 | 5,196,599 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 109.98 per share. | 19 Nov 2021 | 21,468 | 50,250 (0%) | 0% | 110.0 | 2,361,051 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 110.44 per share. | 19 Nov 2021 | 250 | 50,000 (0%) | 0% | 110.4 | 27,610 | Class A Common Stock |
| UroGen Pharma | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 3,000 | 86,504 (0%) | 0% | 0 | Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 390 | 3,031 (0%) | 0% | 0 | Class A Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 639.65 per share. | 27 May 2021 | 78 | 3,109 (0%) | 0% | 639.7 | 49,893 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 639.64 per share. | 27 May 2021 | 25 | 3,134 (0%) | 0% | 639.6 | 15,991 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Grant, award, or other acquisition of securities at price $ 639.71 per share. | 27 May 2021 | 7 | 3,141 (0%) | 0% | 639.7 | 4,478 | Class A Common Stock |
| Arcus Biosciences Inc | Kathryn E. Falberg | Director | Purchase of securities on an exchange or from another person at price $ 28.35 per share. | 31 Mar 2021 | 20,000 | 102,106 (0%) | 0% | 28.3 | 566,996 | Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | 19 Nov 2020 | 20,000 | 0 | - | - | Class B Common Stock | ||
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2020 | 20,000 | 20,000 | - | - | Class B Common Stock | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2020 | 20,000 | 10,303 | - | - | Employee Stock Option (Right to Buy) | |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | 19 Nov 2020 | 20,000 | 22,641 (0%) | 0% | 0 | Class A Common Stock | ||
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 811.00 per share. | 19 Nov 2020 | 5,670 | 11,239 (0%) | 0% | 811 | 4,598,370 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 818.15 per share. | 19 Nov 2020 | 4,139 | 4,108 (0%) | 0% | 818.2 | 3,386,323 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 810.19 per share. | 19 Nov 2020 | 2,852 | 16,909 (0%) | 0% | 810.2 | 2,310,662 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 815.00 per share. | 19 Nov 2020 | 1,891 | 8,247 (0%) | 0% | 815 | 1,541,165 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 809.03 per share. | 19 Nov 2020 | 1,853 | 19,761 (0%) | 0% | 809.0 | 1,499,133 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 813.04 per share. | 19 Nov 2020 | 891 | 10,148 (0%) | 0% | 813.0 | 724,419 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 819.06 per share. | 19 Nov 2020 | 825 | 3,283 (0%) | 0% | 819.1 | 675,725 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 807.84 per share. | 19 Nov 2020 | 795 | 21,614 (0%) | 0% | 807.8 | 642,233 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 822.00 per share. | 19 Nov 2020 | 629 | 2,641 (0%) | 0% | 822 | 517,038 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 806.63 per share. | 19 Nov 2020 | 232 | 22,409 (0%) | 0% | 806.6 | 187,138 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 811.68 per share. | 19 Nov 2020 | 200 | 11,039 (0%) | 0% | 811.7 | 162,336 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 820.00 per share. | 19 Nov 2020 | 13 | 3,270 (0%) | 0% | 820 | 10,660 | Class A Common Stock |
| Trade Desk Inc Ordinary | Kathryn E. Falberg | Director | Sale of securities on an exchange or to another person at price $ 814.00 per share. | 19 Nov 2020 | 10 | 10,138 (0%) | 0% | 814 | 8,140 | Class A Common Stock |